Recent research published in the journal Cell Metabolism demonstrated that semaglutide also affects dopamine signaling in the brain reward centers
25 In the early 1990s, despite John Engs team identifying a potential diabetes treatment in exendin-4, it initially lacked attention and funding for development
Biol Bull Rev 14 , 460465 (2024)
The results were significant: At 48 weeks, participants receiving the 12 mg dose achieved a mean weight reduction of 24.2% (approximately 58 pounds or 26.2 kg) 100% of participants on the 8 mg or 12 mg doses lost at least 5% of their body weight More than 90% of participants on the 12 mg dose lost at least 10% of their body weight Nearly half of participants on the highest dose lost 25% or more of their body weight The study also showed improvements in cardiometabolic markers including blood pressure, triglycerides, LDL cholesterol, and fasting glucose
This is a combination of two disorders: bvFTD and amyotrophic lateral sclerosis (ALS)
It helps reveal your natural, even tone
